222 related articles for article (PubMed ID: 21735357)
1. [Metastatic neuroendocrine neoplasms. Non-surgical treatment strategies].
Pavel M
Chirurg; 2011 Jul; 82(7):612-7. PubMed ID: 21735357
[TBL] [Abstract][Full Text] [Related]
2. Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).
de Mestier L; Lepage C; Baudin E; Coriat R; Courbon F; Couvelard A; Do Cao C; Frampas E; Gaujoux S; Gincul R; Goudet P; Lombard-Bohas C; Poncet G; Smith D; Ruszniewski P; Lecomte T; Bouché O; Walter T; Cadiot G;
Dig Liver Dis; 2020 May; 52(5):473-492. PubMed ID: 32234416
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
Auernhammer CJ; Göke B
Gut; 2011 Jul; 60(7):1009-21. PubMed ID: 21378384
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.
Ma ZY; Gong YF; Zhuang HK; Zhou ZX; Huang SZ; Zou YP; Huang BW; Sun ZH; Zhang CZ; Tang YQ; Hou BH
World J Gastroenterol; 2020 May; 26(19):2305-2322. PubMed ID: 32476795
[TBL] [Abstract][Full Text] [Related]
5. [Medical treatment of digestive neuroendocrine tumours].
Panzuto F; Nasoni S; Delle Fave G
Minerva Endocrinol; 2001 Sep; 26(3):145-8. PubMed ID: 11753237
[TBL] [Abstract][Full Text] [Related]
6. Evolution in the treatment of gastroenteropancreatic-neuroendocrine neoplasms, focus on systemic therapeutic options: a systematic review.
Pusceddu S; De Braud F; Festinese F; Bregant C; Lorenzoni A; Maccauro M; Milione M; Concas L; Formisano B; Leuzzi L; Mazzaferro V; Buzzoni R
Future Oncol; 2015; 11(13):1947-59. PubMed ID: 26161929
[TBL] [Abstract][Full Text] [Related]
7. Systemic Therapies for Metastatic Pancreatic Neuroendocrine Tumors.
Hauser H; Gerson DS; Reidy-Lagunes D; Raj N
Curr Treat Options Oncol; 2019 Nov; 20(12):87. PubMed ID: 31776785
[TBL] [Abstract][Full Text] [Related]
8. The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition.
Pobłocki J; Jasińska A; Syrenicz A; Andrysiak-Mamos E; Szczuko M
Nutrients; 2020 May; 12(5):. PubMed ID: 32429294
[TBL] [Abstract][Full Text] [Related]
9. Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors.
Palazzo M; Lombard-Bohas C; Cadiot G; Matysiak-Budnik T; Rebours V; Vullierme MP; Couvelard A; Hentic O; Ruszniewski P
Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):232-8. PubMed ID: 23108416
[TBL] [Abstract][Full Text] [Related]
10. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
Auernhammer CJ; Jauch KW; Hoffmann JN
Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
[TBL] [Abstract][Full Text] [Related]
11. Treatment of liver metastases in patients with digestive neuroendocrine tumors.
Rossi RE; Massironi S; Spampatti MP; Conte D; Ciafardini C; Cavalcoli F; Peracchi M
J Gastrointest Surg; 2012 Oct; 16(10):1981-92. PubMed ID: 22829240
[TBL] [Abstract][Full Text] [Related]
12. [Chemoembolization, immunotherapy and hormone therapy of carcinoid and digestive neuroendocrine tumors].
Gouyon B; Ruszniewski P
Ann Gastroenterol Hepatol (Paris); 1995; 31(2):121-3. PubMed ID: 7618834
[No Abstract] [Full Text] [Related]
13. Update on medical treatment of small intestinal neuroendocrine tumors.
Pusceddu S; Femia D; Lo Russo G; Ortolani S; Milione M; Maccauro M; Vernieri C; Prinzi N; Concas L; Leuzzi L; De Braud F; Buzzoni R
Expert Rev Anticancer Ther; 2016 Sep; 16(9):969-76. PubMed ID: 27353232
[TBL] [Abstract][Full Text] [Related]
14. Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel.
Poncet G; Faucheron JL; Walter T
World J Gastroenterol; 2010 Apr; 16(14):1696-706. PubMed ID: 20380000
[TBL] [Abstract][Full Text] [Related]
15. The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios.
Basu S; Ostwal V
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2453-2455. PubMed ID: 27542673
[No Abstract] [Full Text] [Related]
16. Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract.
Cives M; Strosberg J
Curr Treat Options Oncol; 2017 Mar; 18(3):14. PubMed ID: 28286921
[TBL] [Abstract][Full Text] [Related]
17. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
Desai KK; Khan MS; Toumpanakis C; Caplin ME
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
[TBL] [Abstract][Full Text] [Related]
18. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
19. The role of cytoreductive hepatic surgery as an adjunct to the management of metastatic neuroendocrine carcinomas.
Hodul P; Malafa M; Choi J; Kvols L
Cancer Control; 2006 Jan; 13(1):61-71. PubMed ID: 16508628
[TBL] [Abstract][Full Text] [Related]
20. Systemic treatment of neuroendocrine tumors with hepatic metastases.
Demirkan BH; Eriksson B
Turk J Gastroenterol; 2012; 23(5):427-37. PubMed ID: 23161287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
